Robert Klein, DPM
Foot Surgery · Eden, NCNPI 1205975133
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $4,300 of the $5,491 with a category attached, or 78.3%. Darco International, Inc. accounts for 78.3% of it on its own, with 5 other manufacturers making up the rest. 2025 is the largest year on record at $4,327, more than ten times the $20 reported in 2019.
Across 11 payments — averaging $499.16 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Darco International, Inc.$4K
- Solventum Corporation$1K
- Amgen$105
- AbbVie$42
- Organogenesis Inc.$34
- Polymedics Innovations Inc.$3
What the payments were for
- Consulting fees$4,30078%
- Travel & lodging$88216%
- Food & beverage$3096%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Darco International, Inc. | 1 | $4,300 |
| Solventum Corporation | 3 | $1,007 |
| Amgen | 2 | $105 |
| AbbVie | 2 | $42 |
| Organogenesis Inc. | 2 | $34 |
| Polymedics Innovations Inc. | 1 | $3 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- V.A.C. VERAFLO$882
- Curos$125
- ATTEST$125
- 3M SoluPrep$125
- KERRAMAX CARE$125
- V.A.C. ULTA$125
How this compares
Too few foot surgery providers in North Carolinato place this figure against a meaningful peer group, so we don't.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ammonium Lactate | 54 | $1,250 |
| Gabapentin | 29 | $518 |
| Econazole Nitrate | 28 | $495 |
| Cefdinir | 22 | $372 |
| Terbinafine Hcl | 47 | $357 |
| SsdSilver Sulfadiazine | 19 | $292 |
| Doxycycline Hyclate | 12 | $166 |
| Ibuprofen | 26 | $95 |
| Silver Sulfadiazine | 13 | $84 |
Paid to pharmacies, not to this prescriber.
Other foot surgery in Eden
- Thomas ArneWinston Salem$20K
- Bryan SatterwhiteShallotte$4K
- Christopher YoungWilmington$3K
- Scott BasingerCharlotte$2K
- Bennett EvansFayetteville$1K
- Reagan ParrishMorehead City$733
- Devin RicksFayetteville$472
- Tori Simmons LewisCharlotte$370
- Rosemary MichelFayetteville$163
- Kerry SmithWilmington$102
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.